MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.

J Exp Clin Cancer Res · 2011 · PMC3161894 · PMID 21819631

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slightly increasing trendno p-value reported

However, we did not observe a significant difference in the rate of growth inhibition between miR-106b group and blank control group; although a slightly increasing trend of cell survival rate and G0/G1 phase was seen in Hep-2 and TU212 cells.

also in 801 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.